ArticleThe Journal of international medical research2026
TriDermCancerNet: A hybrid deep learning framework for skin cancer classification.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveSkin cancer diagnosis via automated image analysis remains a challenging task due to poor image contrast, visual similarity among lesion classes, and class imbalance in available datasets. To address these issues, this study proposes a novel Tri Model Dermatology Cancer Neural Network (TriDermCancerNet) for classifying skin cancer from dermoscopic images.MethodsTwo publicly available datasets are used in this work: the International Skin Imaging Collaboration 2018 and 2019 datasets, which contain multiple classes of cancer types. In the proposed model framework, a contrast enhancement technique was applied to improve image quality, followed by data augmentation to balance the datasets. The proposed TriDermCancerNet architecture is designed based on the key challenges of this work, including dataset variability, interclass similarity, and model explainability. The proposed architecture integrates three modules: a 105-layer Inception module, a 186-layer Inverted Bottleneck Residual module, and the Dense-177 module. Each module was integrated into the proposed network in parallel rather than in series. Thereafter, each module was trained, and features were extracted and fused using a depth concatenation approach. During training, several important hyperparameters were selected using Bayesian optimization, and the final model was used for classification in the testing phase.ResultsThe fused TriDermCancerNet achieved 98.6% accuracy, 98.6% sensitivity, 98.6% F1-score, and an area under the curve of 1.0 on the International Skin Imaging Collaboration 2018 dataset and 99.7% accuracy, 99.6% sensitivity, 99.6% F1-score, and an area under the curve of 1.0 on the International Skin Imaging Collaboration 2019 dataset. Statistical significance testing confirmed that the fusion model outperforms each branch (p < 0.05).ConclusionThe proposed hybrid TriDermCancerNet approach enhances the precision and robustness of skin cancer classification frameworks, providing clinicians with a valuable diagnostic aid for early detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.